In this article NOC TAP YUM TPX MRK CMCSA Check out the companies making headlines before the bell: Comcast (CMCSA) – Comcast rose 1.9% in the premarket after reporting adjusted quarterly earnings of 84 cents per share, beating the consensus estimate of 67 cents. The NBCUniversal parent also reported better-than-expected revenue, helped by a rebound
0 Comments
If you need money in an emergency, one place to look is your insurance policy. That is if what you have is permanent life insurance – available as either “whole life” and “universal life.” Unlike term life insurance, which has a set time limit on its coverage period and does not accumulate cash value, universal life
0 Comments
MicroStrategy CEO Michael Saylor on Friday defended his enterprise software company’s debt-financed purchases of bitcoin, telling CNBC he sees buying the cryptocurrency right now as comparable to investing in Facebook in the social network’s early days. “We’ve got $2.2 billion of debt and we pay about 1.5% interest, and we have a very long time
0 Comments
Jeff Bezos, owner of Blue Origin, introduces a new lunar landing module called Blue Moon during an event at the Washington Convention Center, May 9, 2019 in Washington, DC. Mark Wilson | Getty Images The U.S. Government Accountability Office on Friday denied protests from companies affiliated with Jeff Bezos that NASA wrongly awarded a lucrative
0 Comments
ContextLogic (NASDAQ:WISH) is well-positioned to benefit from the turbulence that China-based e-commerce companies are facing. Further, after outlining multiple, positive catalysts in my previous column on WISH stock, published on June 28, I have identified several more drivers that are likely to boost the shares over the longer term. Source: sdx15 / Shutterstock.com Among these
0 Comments
Penn National (NASDAQ:PENN) has generated profits in each of the last two quarters — and the company’s first-quarter results were particularly impressive. But that’s not the only reason to like PENN stock. Source: Casimiro PT / Shutterstock.com On top of its quarterly performance, Penn National also looks critically well-positioned to benefit from a meaningful expansion
0 Comments
A decade ago, after returning to finance from 30 years covering computer technology, I got into an argument over a company called Dendreon. You’ll see why this lingering thoughts connects me to BIIB stock below. Source: PictureDesignSwiss / Shutterstock.com Dendreon had launched a treatment for prostate cancer called Provenge. It is an immunotherapy, tied to
0 Comments